Virax Biolabs Group Ltd
viraxbiolabs.comWhat Do They Do?
Develops immune-profiling and diagnostic tests for viral and immune-related diseases, and sells peptide pools, ELISpot plates and related research reagents to laboratories and biopharmaceutical companies.
20-F for FY2026, filed Jul 6, 2026We are a biotechnology company focused on immune response detection, T cell immune profiling and the development of in vitro diagnostic…View ↗
(i) ViraxImmune™, our lead in-development T cell-based immune profiling and diagnostic platform; and (ii) ImmuneSelect, our…View ↗
Alongside ViraxImmune™, the Company is developing and commercializing its ImmuneSelect RUO portfolio. ImmuneSelect includes peptide pools…View ↗
Who Are Their Customers?
Research organizations, academic institutions, contract research organizations, biopharmaceutical companies and independent laboratories buy RUO products; sales use direct engagement and distributor relationships.
20-F for FY2026, filed Jul 6, 2026
Do Revenues Turn Into Profits?
No. It lost $5M in .
20-F for FY2026, filed Jul 6, 2026
How Are They Changing?
From test kits to research reagents
The older report centered sales on distributing third-party ViraxClear test kits and described ViraxImmune as a product in development. The latest report identifies ViraxImmune as its lead development program and ImmuneSelect as a commercialized research-use offering; ViraxClear and ViraxVet are no longer active strategic product lines.
20-F for FY2023, filed Jun 14, 2023 20-F for FY2026, filed Jul 6, 2026(i) ViraxImmune™, our lead in-development T cell-based immune profiling and diagnostic platform; and (ii) ImmuneSelect, our…View ↗
The Company previously distributed third-party test kits under the ViraxClear and ViraxVet brands. These historical product lines generated…View ↗
Alongside ViraxImmune™, the Company is developing and commercializing its ImmuneSelect RUO portfolio. ImmuneSelect includes peptide pools…View ↗
During fiscal year 2026, the Company generated limited revenue from sales of RUO products. The Company’s historical revenues in fiscal…View ↗
Who Do They Compete With?
Competes with QIAGEN, Adaptive Biotechnologies, Roche Holding, and Abbott Laboratories
20-F for FY2026, filed Jul 6, 2026We may face competition from companies such as QIAGEN N.V., Adaptive Biotechnologies Corporation, Roche Holding AG, Abbott Laboratories and…View ↗
Loading...
